- Home
- LMB vs INVA Comparison
LMB vs INVA Comparison
Compare LMB & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LMB | INVA |
|---|---|---|
| Founded | 1901 | 1996 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.7B |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LMB | INVA |
|---|---|---|
| Price | $77.43 | $22.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $130.00 | $36.50 |
| AVG Volume (30 Days) | 160.9K | ★ 595.3K |
| Earning Date | 06-10-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.68 | ★ 816.67 |
| EPS | 3.23 | ★ 3.30 |
| Revenue | ★ $646,804,000.00 | $217,217,000.00 |
| Revenue This Year | $16.50 | $8.78 |
| Revenue Next Year | $4.76 | $11.99 |
| P/E Ratio | $24.89 | ★ $6.73 |
| Revenue Growth | 24.68 | ★ 62.63 |
| 52 Week Low | $63.02 | $16.52 |
| 52 Week High | $154.04 | $25.15 |
Technical Indicators
Market Signals| Indicator | LMB | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 48.66 |
| Support Level | $65.08 | $19.16 |
| Resistance Level | $85.30 | $22.76 |
| Average True Range (ATR) | 6.00 | 0.64 |
| MACD | -1.38 | -0.18 |
| Stochastic Oscillator | 6.98 | 13.63 |
Price Performance
Historical ComparisonAbout LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.